Healthcare -
Biotechnology - NYSE - CH
$ 1.83
4.57 %
$ 177 M
Market Cap
-0.77
P/E
ADCT - OPERATING INCOME
Operating Income ADCT - ADC Therapeutics SA
-166 M
LAST VALUE
20.36%
2 YEAR CAGR
-5.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR